Boys should be given HPV jab, says vaccine committee

July 19, 2018, Cancer Research UK
Boys should be given HPV jab, says vaccine committee
Human papillomavirus (HPV) vaccine. Credit: Wikimedia Commons/CC BY-SA 2.0

It's nearly a decade since the human papillomavirus (HPV) vaccine was first introduced in the UK to help protect against the virus that causes most cases of cervical cancer. But until now, it has only been routinely offered to girls.

Today, the Joint Committee for Vaccination and Immunisation (JCVI) recommended that adolescent boys should now also receive the vaccine.

When and how this will happen is now down to the Government. But the recommendation comes from years of mounting evidence around likely health benefits and overall .

HPV and cancer

HPV is a big family of viruses. There are more than 100 different types and some are more dangerous than others. While some low risk types cause growths like warts or verrucas, there are thirteen high-risk types that are linked to .

HPV is very common, with 8 in 10 people infected at some p oint in their life. Usually our bodies clear the infection without it causing any problems. But in some cases a lasting infection can lead to cancer.

This is because the virus damages the infected cells' DNA and causes them to start dividing out of control, setting them on the road to cancer.

Thanks to the vaccination programme, many people know that HPV causes – in fact it's linked to all cases of the disease in the UK. But HPV is linked to other cancers too – including anal, penis and some types of mouth and throat cancer.

Why wasn't the HPV vaccine always available for boys?

The HPV vaccine protects against 4 types of HPV. Two are linked to cancer: HPV 16 and 18, which together cause around 7 in 10 cervical cancer cases in the UK. The vaccine also protects against HPV 6 and 11, which cause most .

The vaccine has been available to girls in the UK since 2008. It was initially only recommended for girls as the strongest evidence of health benefits and cost effectiveness was for cervical cancer and genital warts.

Since the vaccine was introduced, we're starting to see HPV infections in people who have been vaccinated falling. This suggests the vaccine is preventing HPV infection and, in the future, this should prevent cervical cancers.

But HPV is linked to cancers in men as well as women.

Together these add up to more than 8,000 cancer cases each year in the UK. Credit: Cancer Research UK

Men who have sex with women will get some protection from the current vaccination programme if their partner is vaccinated. The same can't be said for adult men who have sex with men .

In 2015, the JCVI, which advises UK health departments on vaccines, recommended extending vaccination to adult men who have sex with men. This group of men are at a higher risk of anal cancer. Up to the age of 45, these men can request HPV vaccination at sexual health clinics.

But up until today, the programme hadn't been recommended for boys, as the JCVI weren't convinced it would be cost-effective.

Today's decision brings the UK in line with other countries including the US and Australia, which already offer the vaccination to boys.

Who will be offered the vaccine?

The JCVI has recommended the vaccine for boys aged 11-13, similar to the vaccination programme for girls. HPV vaccination is most effective in people who haven't ever had an HPV infection. And as HPV is mostly transmitted through close sexual contact, vaccination is offered at a young age when people are unlikely to have had any sexual experiences.

Men above the vaccination age who don't have sex with men won't be offered the vaccine. But it's important to remember that most people clear HPV infections without them causing any symptoms or problems. And for most cancers linked to HPV there are also other ways to reduce your risk through things like not smoking or drinking less alcohol.

What happens now?

The recommendation for a gender neutral vaccination programme for adolescents has been years in the making. The next step is for the Government to formally accept the recommendation and extend the programme to boys.

Until it does, we won't know the details of when and how the programme will be rolled out. Once they have accepted the recommendation, the Government must publish a plan and timetable for the roll-out.

This will need to be accompanied by more details on the programme itself. When the vaccine was first offered to girls in the UK, a 'catch-up' programme was introduced for girls up to the age of 18, and we want the Government to do the same for boys.

Finally, the programme will do nothing if people aren't aware it's happening. We want to see a national awareness campaign to clearly communicate about the vaccine and its potential benefits, as well as new information for parents and boys.

By offering the to everyone aged 11-13, the number of cases of HPV, along with the cancers they cause, could be dramatically reduced in the future.

Explore further: Parents want the HPV vaccine for their sons – new research

Related Stories

Parents want the HPV vaccine for their sons – new research

April 12, 2018
Human papillomavirus (HPV) is a sexually transmitted infection that causes diseases that affect both men and women. In the UK, girls are vaccinated against HPV but boys are not.

A great majority of Mozambican adolescent girls are willing to be vaccinated against HPV

June 5, 2018
A study in Mozambique reveals that a majority of adolescent girls interviewed would be willing to be vaccinated against the human papilloma virus (HPV) if the vaccine were available in the country. These results are encouraging ...

Many doctors don't push HPV shots equally. See who's left out

March 26, 2018
(HealthDay)—Teen boys in the United States are less likely than girls to be vaccinated against human papillomavirus (HPV) because many doctors don't recommend the shots to boys' parents, researchers say.

Facts women and men should know about cervical cancer

January 22, 2018
January is Cervical Cancer Awareness month and the message from the Centers from Disease Control and Prevention is that "no woman should die from cervical cancer."

More U.S. teens getting vaccinated against HPV

August 24, 2017
(HealthDay)—Six out of 10 U.S. parents are choosing to get their children vaccinated against the cancer-causing human papillomavirus (HPV), which is spread by sexual contact, federal health officials reported Thursday.

President's panel calls for more girls, boys to get HPV vaccine

February 10, 2014
(HealthDay)—Too few American girls and boys are getting vaccinated against the cancer-causing human papillomavirus (HPV), the President's Cancer Panel reported Monday.

Recommended for you

Pushing closer to a new cancer-fighting strategy

December 11, 2018
A molecular pathway that's frequently mutated in many different forms of cancer becomes active when cells push parts of their membranes outward into bulging protrusions, Johns Hopkins researchers report in a new study. The ...

Scientists have identified and modelled a distinct biology for paediatric AML

December 11, 2018
Scientists have identified and modelled a distinct biology for paediatric acute myeloid leukaemia, one of the major causes of death in children.

HER2 mutations can cause treatment resistance in metastatic ER-positive breast cancer

December 11, 2018
Metastatic breast cancers treated with hormone therapy can become treatment-resistant when they acquire mutations in the human epidermal growth factor receptor 2 (HER2) that were not present in the original tumor, reports ...

Loss of two genes drives a deadly form of colorectal cancer, reveals a potential treatment

December 11, 2018
Colorectal cancers arise from earlier growths, called polyps, found on the inner surface of the colon. Scientists are now learning that polyps use two distinct molecular pathways as they progress to cancer, called the "conventional" ...

Taking uncertainty out of cancer prognosis

December 11, 2018
A cancer diagnosis tells you that you have cancer, but how that cancer will progress is a terrifying uncertainty for most patients. Researchers at Cold Spring Harbor Laboratory (CSHL) have now identified a specific class ...

Successful anti-PD-1 therapy requires interaction between CD8+ T cells and dendritic cells

December 11, 2018
A team led by a Massachusetts General Hospital (MGH) investigator has found that successful cancer immunotherapy targeting the PD-1 molecule requires interaction between cytotoxic CD8+ T cells, which have been considered ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.